A. Schietinger
Immunology · 2013–2021
A researcher in the Science corpus: 7 papers; trusts 16 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 187 citations into it; #1,050 of 2,160 by trust here, #675 by citations
- Oncology — 142 citations into it
Whom A. Schietinger trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- E. Wherry
- Ronald H. Schwartz
- J. Wherry
- Daniel L. Barber
- S. Kaech
- Rafi Ahmed
- M. Keir
- S. Topalian
- F. Quintana
- G. Freeman
Who trusts A. Schietinger overall
Papers from A. Schietinger's perspective
Ordered by how strongly the researchers A. Schietinger trusts endorse each paper. Same corpus, a different order for every researcher.
- Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- T cell exhaustion (Nature Immunology)
- Memory CD8 T-Cell Differentiation during Viral Infection (Journal of Virology)
- Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens (Nature)
- PD-1 and its ligands in tolerance and immunity. (Annual Review of Immunology)
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients (Journal of Experimental Medicine)
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression (Nature)
- Coregulation of CD8+ T cell exhaustion during chronic viral infection by multiple inhibitory receptors (Nature Immunology)
Their papers
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021) — 1,066 citations
- CD8+ T cell differentiation and dysfunction in cancer (2021) — 857 citations
- Defining ‘T cell exhaustion’ (2019) — 1,291 citations
- TOX is a critical regulator of tumour-specific T cell differentiation (2019) — 942 citations
- Chromatin states define tumor-specific T cell dysfunction and reprogramming (2017) — 829 citations
- Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis (2016) — 623 citations
- Tolerance and Exhaustion: Defining Mechanisms of T cell Dysfunction (2013) — 633 citations